Ocugen (OCGN) Other Operating Expenses (2014 - 2020)

Ocugen's (OCGN) quarterly Other Operating Expenses came in at $7.0 million in Q3 2020, up 350.99% on a QoQ basis from -$2.8 million in Q1 2019.

Ocugen (OCGN) Other Operating Expenses (2014 - 2020) Analysis & Trends

Ocugen (OCGN) has 5 years of Other Operating Expenses data on file, last reported at $7.0 million in Q3 2020.

Quarterly Other Operating Expenses changed N/A year-over-year to $7.0 million in Q3 2020, while the trailing twelve-month figure through Jun 2021 was $7.0 million (changed N/A YoY) and the FY2020 annual result came in at $7.0 million, changed N/A from the prior year.
Other Operating Expenses advanced to $7.0 million in Q3 2020, from -$2.8 million in the prior quarter.
In the past five years, Other Operating Expenses ranged from a high of $7.0 million in Q3 2020 to a low of -$2.8 million in Q1 2019.
A 3-year average of $1.5 million and a median of $200000.0 in 2016 frame the typical range for Other Operating Expenses.
The widest YoY moves for Other Operating Expenses: up 35.48% in 2016, down 35.48% in 2016.
Tracing OCGN's Other Operating Expenses over 3 years: stood at $200000.0 in 2016, then sank by 1494.5% to -$2.8 million in 2019, then jumped by 350.99% to $7.0 million in 2020.
The last three Other Operating Expenses figures came in at $7.0 million (Q3 2020), -$2.8 million (Q1 2019), and $200000.0 (Q4 2016), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Ocugen	457.71 Mn	357.61 Mn	-

Download Data